Skip navigation

Study Data Tabulation Model


Team Charters:



CDISC Study Data Tabulation Model (SDTM) v1.4, Study Data Tabulation Model Implementation Guide (SDTMIG) v3.2 and Associated Persons Implementation Guide (SDTMIG-AP) v1.0 Final Documents Released!


The CDISC SDS Team is pleased to announce the release of SDTM v1.4, SDTMIG v3.2, and SDTMIG-AP v1.0. The updates to these documents include:


SDTM: The addition of new variables to the general observation classes for both human clinical trials and SEND;

SDTMIG: A completely re-designed SDTMIG as a PDF Portfolio instead of the traditional single PDF file. 11 New Domains: EC, PR, HO, DD, IS, MI, MO, RP, SR, SS, and TD

SDTMIG-AP: A brand new IG to describe how to represent collected data about persons other than the subject under study, who could be associated with the study itself, a particular study subject, or a device used in the study


IMPORTANT: Inside the SDTMIG please read the PDF document “PDF Portfolios at a Glance” first. This document provides information of the SDTMIG v3.2 in its new format and how to navigate through it.


Note that all of previous annotations in SDTMIG 3.1.3, originally published in 2012, have been incorporated in SDTMIG v3.2.


  1. Download Study Data Tabulation Model v1.4 only
  2. Download SDTMIG v3.2 only (Upon clicking on this link, please download the latest Adobe version or click on the top right corner where you see "Open with Different Viewer" link to download the document).
  3. Download SDTMIG-AP v1.0 only



**Some browsers may have difficulty viewing PDF portfolios, which require Adobe Flash. If you cannot view the portfolio, you can download this document as a single PDF here, though you will not be able to capitalize on the portfolio's advanced navigation features** Click here to download the SDTMIG v3.2.


SDTM Implementation Guide for Medical Devices – Now Available

The Study Data Tabulation Model Guide for Medical Devices (SDTMIG-MD) v.1.0 is now available. This standard defines recommended standards for the submission of data from clinical trials in which medical devices are used. The document includes seven new domains, developed by a team comprised of medical device experts, CDISC experts, and the FDA (CDRH and CBER), and represents years of work by the members of the CDISC Medical Device team. Training on these seven new domains has been incorporated into the standard SDTM training available through CDISC. Follow the link.



CDISC Study Data Tabulation Model (SDTM) v1.3 and Study Data Tabulation Model Implementation Guide (SDTMIG) v3.1.3 final documents released

The CDISC SDS Team is pleased to announce the release SDTM v1.3 and SDTMIG v3.1.3. The updates to these documents include:


  • The addition of new variables to the general observation classes for both human clinical trials and SEND;
  • The incorporation of the content previously published in the SDTM Amendment 1; 
  • Changes to the Trial design section;
  • Document formatting updates;
  • Inclusion of the TU/TR/RS Oncology domains developed as the Oncology Disease-specific Therapeutic Area Supplement.


IMPORTANT: Please read the PDF document “How to Use SDTMIG 3.1.3” first. This document provides information of the SDTMIG 3.1.3 documentation package and, as the title implies, how to use it.


Note that all of Amendment 1 to the SDTM v1.2 and SDTMIG v3.1.2, originally published in 2011, has been incorporated in SDTMIG v3.1.3.


Follow the link to download the zip file containing the Documentation package.



A spreadsheet including all metadata tables from SDTM v1.3 and SDTMIG v3.1.3 is now available in the Member's Only area.



Standards in Production


Metadata Submission Guideline (MSG) Package Preface

The CDISC Submission Data Standards (SDS) Metadata Team has released the final version 1.0 of the Metadata Submission Guidelines (MSG) Package. The package was originally released for public comment from 2010-05-14 to 2010-06-07. During that review period, over 570 comments were received, all of which needed to be resolved before this final package could be released. Included with the package is the Metadata Submission Guidelines (MSG), an appendix to the Study Data Tabulation Model Implementation Guide 3.1.2, which will enable users to become familiar with the SDTM submission components. Included in this posting is a sample electronic submission which includes an annotated CRF, submission datasets compliant with the SDTM-IG 3.1.2, a define.xml file describing the structure and content of the submitted datasets, a stylesheet for visualizing the define.xml in a user-friendly way, and an optional Reviewers’ Guide.


Please access the folder through the link located at the bottom of this page.


The FDA can now accept SDTM V3.1.2.

FDA announced on 6 November 2009 that they will accept SDTM V3.1.2 submissions. Please read the latest version of the Study Data Specifications (1.5.1) here.

In addition, other documents related to the Study Data Standards Resources can be found here.


Please note the following taken directly from the document: Sponsors "should discuss with the review division the datasets that should be provided, the data elements that should be included in each dataset, and the organization of the data within the file. Additionally, not all FDA centers have adopted all aspects of these specifications; sponsors are advised to discuss with the reviewing division data needs prior to preparing data for submission."

Metadata Submission Guideline (MSG) Package Preface  |  Non Members
SDTM V1.1 & SDTM IG V3.1.1  |  Non Members
SDTM V1.2 & SDTM IG V3.1.2  |  Non Members

New CDISC Member Application

To register for a new membership, please supply the following information.

Please read the details on the membership page BEFORE you apply.

Please also check that your company is not already a member of CDISC here: CDISC Members.

For membership benefits and rates click here